Testing the similarity of an injectable medicine in healthy adults
Treatments studied
This study checks if a new injectable medication (RAY1225) behaves the same in the body as the original version. It is for healthy adults and will compare the two forms to make sure they are alike.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult and able to follow study instructions.
- If you are male, you need to weigh at least 55 kg (about 121 lbs); if female, at least 50 kg (about 110 lbs).
- You and your partner must use reliable birth control during the study and for 3 months after the last dose.
- You must not have a history of certain thyroid problems (like medullary thyroid cancer) or conditions related to it.
- You must not have had a major surgery, severe infection, or low blood sugar episodes recently.
- You must not have taken any prescription or over-the-counter medications, or Chinese medicine, in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gives healthy people a single shot of a study drug that has a tiny radioactive label, then tracks how it moves through the body. It helps researchers learn how the drug is absorbed and removed, which is a key step before it can be tested as a possible treatment for weight-related conditions.
This study gives healthy men a single dose of a new medicine to see how the body absorbs, uses, and removes it over time. It helps researchers understand the drug's safety and behavior before it is tested in patients.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This trial tests a new drug called QLS2312, given as an injection, to see if it is safe and how the body handles it. It is an early study in healthy volunteers that helps decide if the drug can be studied in people with certain conditions.
This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This trial tests a new supplement called MIB-725, given as a single dose to see how safe it is and how the body handles it. Healthy adults aged 19 to 60 who don't smoke and are not on certain medications may join.
Hear when a new Basic Science trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.